Literature DB >> 17531531

Low frequency repetitive transcranial magnetic stimulation over premotor cortex can improve cortical tremor.

E Houdayer1, H Devanne, L Tyvaert, L Defebvre, P Derambure, F Cassim.   

Abstract

OBJECTIVE: To examine the effects of a 30 min, 1 Hz subthreshold rTMS in a case of cortical tremor which is caused by hyperexcitability of sensorimotor cortex.
METHODS: Stimulation was applied over primary and, in a second time, over premotor cortex (M1 and PMC, respectively). Tremor was monitored by accelerometers placed on the index fingers of hands outstretched, before and several times after rTMS. Each rTMS session consisted of 1800 pulses delivered at 1 Hz with an intensity of 90% of resting motor threshold.
RESULTS: PMC but not M1 stimulation led to a decrease of the postural tremor (90% decrease of acceleration total spectral power). This functional benefit was associated to normalization of electrophysiologic parameters (short-interval intracortical inhibition and cortical silent period duration). Moreover, when stimulating PMC during two daily sessions, improvement of the tremor was longer than one day stimulation and this benefit was associated with functional improvement.
CONCLUSIONS: This study shows that 1 Hz rTMS over premotor cortex can improve cortical tremor. SIGNIFICANCE: These results raise the interest of the motor cortical stimulation as a possible therapeutic target for treatment of action tremor.

Entities:  

Mesh:

Year:  2007        PMID: 17531531     DOI: 10.1016/j.clinph.2007.04.014

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  2 in total

1.  The effects of low- and high-frequency repetitive TMS on the input/output properties of the human corticospinal pathway.

Authors:  E Houdayer; A Degardin; F Cassim; P Bocquillon; P Derambure; H Devanne
Journal:  Exp Brain Res       Date:  2008-02-08       Impact factor: 1.972

Review 2.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.